After 10 months of planning and community engagement, the University of Chicago Medicine has updated its original proposal to build the city’s first freestanding cancer hospital with an enhanced design that incorporates feedback from patients and residents of the South Side. The new cost and size of the project is $815 million for a 575,000-square-foot facility, with the ability for future expansion.
The project’s scope reflects community-driven, patient-focused changes made following the Illinois Health Facilities and Services Review Board’s approval of a master design permit in March 2022. The permit allowed UChicago Medicine to spend money on design and site planning and afforded the time to get input from members of the community, cancer patients and survivors.
Changes to the cancer center project include patient-focused enhancements including a redesign of the ground-floor space to be a community hub for cancer prevention, screening and diagnoses, as well as private infusion bays, a dedicated breast center and shell space for future growth and technologies that have yet to be developed. The facility represents one of UChicago Medicine’s largest investments in the South Side community.
The new proposal is outlined in UChicago Medicine’s Certificate of Need application, which was filed with the state Review Board this month and seeks approval for the full construction of the cancer hospital. The new cancer hospital would consolidate care that is currently spread across at least five buildings on UChicago Medicine’s Hyde Park campus, which is the hub of the academic health system.
Click here to read the full story.
This story was first published by UChicago Medicine.
